GlassScriptPhysician profile
Sara E Zelinskas
NPI 1013229897
$4,587.89
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,217 · 2020: $138 · 2021: $290 · 2023: $943.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $754 · Food and Beverage: $189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $753.67 |
| Food and Beverage | $189.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supreme Orthopedic Systems, LLC | $1,693.72 | 2019 | |
| Arthrex, INC. | $1,256.08 | 2019-2023 | |
| Stryker Corporation | $654.47 | 2019-2021 | |
| Wardlow Enterprises | $649.06 | 2023 | |
| Wright Medical Technology, INC. | $150.50 | 2019-2020 | |
| Integra Lifesciences Corporation | $42.64 | 2019-2021 | |
| Orthofix Medical, INC. | $32.06 | 2019 | |
| Misonix INC | $31.91 | 2019-2021 | |
| Smith+Nephew, INC. | $29.66 | 2020-2023 | Panta 2, Integraallograft Wedge System |
| Fortis Surgical, LLC | $22.65 | 2020 | |
| Bioventus LLC | $13.57 | 2021 | |
| Novo Nordisk INC | $11.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Zelinskas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.